Mood disorders in the medically ill: Scientific review and recommendations

Biological Psychiatry

Volumn 58, Issue 3, 2005, Pages 175-189

  Evans, Dwight L ^h,ab   Charney, Dennis S ^b,l   Lewis, Lydia ^v   Golden, Robert N ⁿ   Gorman, Jack M ^l   Krishnan, K Ranga Rama ^o   Nemeroff, Charles B ^a   Bremner, J Douglas ^a   Carney, Robert M ^ac   Coyne, James C ^h   Delong, Mahlon R ^a   Frasure Smith, Nancy ^j   Glassman, Alexander H ^k   Gold, Philip W ^c   Grant, Igor ^p   Gwyther, Lisa ^o   Ironson, Gail ^r   Johnson, Robert L ^t   Kanner, Andres M ^u   Katon, Wayne J ^w   Kaufmann, Peter G ^d   Keefe, Francis J ^o   Ketter, Terence ^q   Laughren, Thomas P ^f   Leserman, Jane ⁿ   Lyketsos, Constantine G ^g   McDonald, William M ^a   McEwen, Bruce S ^m   Miller, Andrew H ^a   Musselman, Dominique ^a   O'Connor, Christopher ^o   Petitto, John M ^s   Pollock, Bruce G ⁱ   Robinson, Robert G ^y   Roose, Steven P ^k   Rowland, Julia ^e   Sheline, Yvette ^b   Sheps, David S ^s   Simon, Gregory ^x   Spiegel, David ^q   Stunkard, Albert ^h   Sunderland, Trey ^c   Tibbits Jr , Paul ^z   Valvo, William J ^aa   more..

^a EMORY UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^g JOHNS HOPKINS UNIVERSITY   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ UNIVERSITY OF PITTSBURGH   (United States)

^j MCGILL UNIVERSITY   (Canada)

^k Och Spine at New York Presbyterian Hospitals   (United States)

^l MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^m ROCKEFELLER UNIVERSITY   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^o DUKE UNIVERSITY   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q STANFORD UNIVERSITY   (United States)

^r UNIVERSITY OF MIAMI   (United States)

^s UNIVERSITY OF FLORIDA   (United States)

^t UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^u RUSH UNIVERSITY MEDICAL CENTER   (United States)

^v Depression and Bipolar Support Alliance (DBSA)   (United States)

^w UNIVERSITY OF WASHINGTON   (United States)

^x CENTER FOR HEALTH STUDIES   (United States)

^y UNIVERSITY OF IOWA   (United States)

^z AMERICAN DIABETES ASSOCIATION   (United States)

^aa Mended Little Hearts   (United States)

^ab UNIVERSITY OF PENNSYLVANIA   (United States)

^ac NONE

more..

Author keywords

Antidepressant therapy; Depression; Medical comorbidity; Mood disorders

Indexed keywords

ALPHA INTERFERON; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; HYPERICUM PERFORATUM EXTRACT; LITHIUM; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NEUROLEPTIC AGENT; NOMIFENSINE; ORAL ANTIDIABETIC AGENT; PAROXETINE; PRASTERONE; PROTEINASE INHIBITOR; PSYCHOSTIMULANT AGENT; SEROTONIN UPTAKE INHIBITOR; TESTOSTERONE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ANXIETY DISORDER; BEHAVIOR THERAPY; BIPOLAR DISORDER; CANCER; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CORRELATION ANALYSIS; DEPRESSION; DIABETES MELLITUS; DISEASE COURSE; EPIDEMIOLOGICAL DATA; EPILEPSY; HEALTH CARE NEED; HEALTH CARE POLICY; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MANIA; MELANOMA; MENTAL HEALTH CARE; METHODOLOGY; MOOD DISORDER; MORBIDITY; MORTALITY; NEUROTOXICITY; OBESITY; OPEN STUDY; OSTEOPOROSIS; PAIN; PARKINSON DISEASE; PARKINSONISM; POPULATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; PSYCHOSOCIAL CARE; REVIEW; RISK FACTOR; SEIZURE; TREATMENT OUTCOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BRAIN DISEASES; CEREBROVASCULAR DISORDERS; COMORBIDITY; DELIVERY OF HEALTH CARE; DIABETES COMPLICATIONS; HUMANS; MOOD DISORDERS; NEOPLASMS; OBESITY; OSTEOPOROSIS; PAIN; PRACTICE GUIDELINES; PREVALENCE;

EID: 23444451611     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.05.001     Document Type: Review

References (274)

1. D.K. Ahern, L. Gorkin, J.L. Anderson, C. Tierney, A. Hallstrom, C. Ewart CAPS Investigators Biobehavioral variables and mortality or cardiac arrest in the Cardiac Arrhythmia Pilot Study (CAPS) Am J Cardiol 66 1990 59 62
2. R. Anda, D. Williamson, D. Jones, C. Macera, E. Eaker, A. Glassman, J. Marks Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults Epidemiology 4 1993 285 294
3. R.F. Anda, D.F. Williamson, L.G. Escobedo, E.E. Mast, G.A. Giovino, P.L. Remington Depression and the dynamics of smoking A national perspective JAMA 264 1990 1541 1545
4. G. Andersen, K. Vestergaard, L. Lauritzen Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram Stroke 25 1994 1099 1104
5. J. Andersen, E. Aabro, N. Gulmann, A. Hjelmsted, H.E. Pedersen Anti-depressive treatment in Parkinson's disease A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA Acta Neurologica Scand 62 1980 210 219
6. R.J. Anderson, R.E. Clouse, K.E. Freedland, P.J. Lustman The prevalence of comorbid depression in adults with diabetes A meta-analysis Diabetes Care 24 2001 1069 1078
7. F. Angst, H.H. Stassen, P.J. Clayton, J. Angst Mortality of patients with mood disorders Follow-up over 34-38 years J Affect Disord 68 2002 167 181
8. A.A. Ariyo, M. Haan, C.M. Tangen, J.C. Rutledge, M. Cushman, A. Dobs, C.D. Furberg Cardiovascular Health Study Collaborative Research Group Depressive symptoms and the risks of coronary heart disease and mortality in elderly Americans Circulation 102 2000 1773 1779
9. J.H. Atkinson, I. Grant, C.J. Kennedy, D.D. Richman, S.A. Spector, J.A. McCutchan Prevalence of psychiatric disorders among men infected with human immunodeficiency virus A controlled study Arch Gen Psychiatry 45 1988 859 864
10. J.C. Barefoot, M. Schroll Symptoms of depression, acute myocardial infarction, and total mortality in a community sample Circulation 93 1996 1976 1980
11. S.S. Bassuk, L.F. Berkman, D. Wypiy Depressive symptomatology and incident cognitive decline in an elderly community sample Arch Gen Psychiatry 55 1998 1073 1081
12. E.G. Bing, M.A. Burnam, D. Longshore, J.A. Fleishman, C.D. Sherbourne, A.S. London Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States Arch Gen Psychiatry 58 2001 721 728
13. S.A. Black, K.S. Markides, L.A. Ray Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes Diabetes Care 26 2003 2822 2828
14. J.A. Blumenthal, R.S. Williams, A.G. Wallace, R.B. Williams, T.L. Needles Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction Psychosom Med 44 1982 519 527
15. K. Bolla-Wilson, R.G. Robinson, S.E. Starkstein, J. Boston, T.R. Price Lateralization of dementia of depression in stroke patients Am J Psychiatry 146 1989 627 634
16. K.W. Brown, A.R. Levy, Z. Rosberger, L. Edgar Psychological distress and cancer survival A follow-up 10 years after diagnosis Psychosom Med 65 2003 636 643
17. J.H. Burack, D.C. Barrett, R.D. Stall, M.A. Chesney, M.L. Ekstrand, T.J. Coates Depressive symptoms and CD4 lymphocyte decline among HIV-infected men JAMA 270 1993 2568 2573
18. M.M. Burg, M.C. Benedetto, R. Rosenberg, R. Soufer Presurgical depression predicts medical morbidity 6 months after coronary artery bypass graft surgery Psychosom Med 65 2003 111 118
19. D.E. Bush, R.C. Ziegelstein, M. Tayback, D. Richter, S. Stevens, H. Zahalsky, J.A. Fauerbach Even minimal symptoms of depression increase mortality risk after acute myocardial infarction Am J Cardiol 88 2001 337 341
20. L.C. Campbell, D.J. Clauw, F.J. Keefe Persistent pain and depression a biopsychosocial perspective Biol Psychiatry 54 2003 399 409
21. R.M. Carney, J.A. Blumenthal, P.K. Stein, L. Watkins, D. Catellier, L.F. Berkman Depression, heart rate variability, and acute myocardial infarction Circulation 104 2001 2024 2028
22. R.M. Carney, K.E. Freedland, S.A. Eisen, M.W. Rich, A.S. Jaffe Major depression and medication adherence in elderly patients with coronary artery disease Health Psychol 14 1995 88 90
23. R.M. Carney, K.E. Freedland, M.W. Rich, L.J. Smith, A.S. Jaffe Ventricular tachycardia and psychiatric depression in patients with coronary artery disease Am J Med 95 1993 23 28
24. R.M. Carney, K.E. Freedland, L. Smith, P.J. Lustman, A.S. Jaffe Relation of depression and mortality after myocardial infarction in women Circulation 84 1991 1876 1877
25. R.M. Carney, K.E. Freedland, P.K. Stein, L.L. Watkins, D. Catellier, A.S. Jaffe, V.K. Yeragani Effects of depression on QT interval variability after myocardial infarction Psychosom Med 65 2003 177 180
26. R.M. Carney, M.W. Rich, A. Tevelde, J. Saini, K. Clark, A.S. Jaffe Major depressive disorder in coronary artery disease Am J Cardiol 60 1987 1273 1275
27. D. Carr, L. Goudas, D. Lawrence, W. Pirl, J. Lau, D. DeVine Management of cancer symptoms Pain, depression and fatigue 2002 Agency for Healthcare Research and Quality Rockville, Maryland July 2002. Evidence Report/Technology Assessment No. 61 (Prepared by the New England Medical Center Evidence-Based Practice Center under Contract No. 290-97-0019.) AHRQ publication No. 02-E032. Available at: http://www.ahrq.gov/clinic/casyminv.htm. Accessed April 29, 2005
28. A.J. Carson, S. MacHale, K. Allen, S.M. Lawrie, M. Dennis, A. House, M. Sharpe Depression after stroke and lesion location A systematic review Lancet 356 2000 122 126
29. R. Ceravolo, A. Nuti, A. Piccinni, G. Del'Agnello, G. Bellini, G. Gambaccini Paroxetine in Parksinon's disease Effects on motor and depressive symptoms Neurology 55 2000 1216 1218
30. P.S. Ciechanowski, W.J. Katon, J.E. Russo Depression and diabetes Impact of depressive symptoms on adherence, function, and costs Arch Intern Med 1160 2000 3278 3285
31. P.S. Ciechanowski, W.J. Katon, J.E. Russo, I.B. Hirsch The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes Gen Hosp Psychiatry 25 2003 246 252
32. J.A. Ciesla, J.E. Roberts Meta-analysis of the relationship between HIV infection and risk for depressive disorders Am J Psychiatry 158 2001 725 730
33. G. Cizza, P. Ravn, G.P. Chrousos, P.W. Gold Depression A major, unrecognized risk factor for osteoporosis? Trends Endocrinol Metab 12 2001 198 203
34. M. Clerici, D. Trabattoni, S. Piconi, M.L. Fusi, S. Ruzzante, C. Clerici, M.L. Villa A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus Psychoneuroendocrinology 22 suppl 1 1997 S27 S31
35. S.W. Cole, Y.D. Korin, J.L. Fahey, J.A. Zack Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production J Immunol 161 1998 610 616
36. I. Connerney, P.A. Shapiro, J.S. McLaughlin, E. Bagiella, R.P. Sloan Relation between depression after coronary artery bypass surgery and 12-month outcome A prospective study Lancet 358 2001 1766 1771
37. P.A. Corley Acquired immune deficiency syndrome The glucocorticoid solution Med Hypotheses 47 1996 49 54
38. D. Costa, I. Mogos, T. Toma Efficacy and safety of mianserin in the treatment of depression of women with cancer Acta Psychiatr Scand Suppl 320 1985 85 92
39. R.T. Croyle Depression as a risk factor for cancer Renewing a debate on the psychobiology of disease J Natl Cancer Inst 90 1998 1856 1857
40. D.G. Cruess, D.L. Evans, M.J. Repetto, D. Gettes, S.D. Douglas, J.M. Petitto Prevalence, diagnosis and pharmacological treatment of mood disorders in HIV disease Biol Psychiatry 54 2003 307 316
41. A.J. Cunningham, C.V. Edmonds, G.P. Jenkins, H. Pollack, G.A. Lockwood, D. Warr A randomized controlled trial of the effects of group psychological therapy on survival in women with metastatic breast cancer Psychooncology 7 1998 508 517
42. M. de Groot, R. Anderson, K.E. Freedland, R.E. Clouse, P.J. Lustman Association of depression and diabetes complications A meta-analysis Psychosom Med 63 2001 619 630
43. W.W. Eaton, H. Armenian, J. Gallo, L. Pratt, E. Ford Depression and risk for onset of type II diabetes A prospective population-based study Diabetes Care 22 1996 1097 1102
44. D.S. Echt, P.R. Liebson, L.B. Mitchell, R.W. Peters, D. Obias-Manno, A.H. Barker CAST Investigators Mortality and morbidity in patients receiving encainide, flecainide, or placebo The Cardiac Arrhythmia Suppression Trial N Engl J Med 324 1991 781 788
45. S. Edelman, J. Lemon, D.R. Bell, A.D. Kidman Effects of group CBT on the survival time of patients with metastatic breast cancer Psychooncology 8 1999 474 481
46. E. Edwards, C. Kitt, E. Oliver, J. Finkelstein, M. Wagster, W.M. McDonald Depression and Parkinson's disease A new look at an old problem Depress Anxiety 16 2002 39 48
47. U. Ehlert, J. Gaab, M. Heinrichs Psychoneuroendocrinological contributions to the etiology of depression, posttraumatic stress disorder, and stress-related bodily disorders The role of the hypothalamus-pituitary-adrenal axis Biol Psychol 57 2001 141 152
48. S.R. Ellen, F.K. Judd, A.M. Mijch, A. Cockram Secondary mania in patients with HIV infection Aust N Z J Psychiatry 33 1999 353 360
49. A.J. Elliott, K.K. Karina, K. Bergam, K. Claypoole, K.K. Uldall, P.P. Roy-Byrne Antidepressant efficacy in HIV-serpositive outpatients with major depressive disorder An open trial of nefazadone J Clin Psychiatry 60 1999 226 231
50. A.J. Elliott, P.P. Roy-Byrne Mirtazapine for depression in patients with human immunodeficiency virus J Clin Psychopharmacol 20 2000 265 267
51. A.J. Elliott, K.K. Uldall, K. Bergam, J. Russo, K. Claypoole, P.P. Roy-Byrne Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed HIV-positive outpatients Am J Psychiatry 155 1998 367 372
52. R.S. el-Mallakh Mania in AIDS Clinical significance and theoretical considerations Int J Psychiatry Med 21 1991 383 391
53. L. Ereshefsky, D. Dugan Review of the pharmacokinetics, pharmacogenetics, and drug interaction potential of antidepressants Focus on venlafaxine Depress Anxiety 12 2000 30 44
54. D.L. Evans, D.S. Charney Mood disorders and medical illness A major public health problem (Editorial) Biol Psychiatry 54 3 2003 177 180
55. D.L. Evans, J.D. Folds, J.M. Petitto, R.N. Golden, C.A. Pedersen, M. Corrigan Circulating natural killer cell phenotypes in men and women with major depression Relation to cytotoxic activity and severity of depression Arch Gen Psychiatry 49 1992 388 395
56. D.L. Evans, J. Leserman, D.O. Perkins, R.A. Stern, C. Murphy, K. Tamul Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection Am J Psychiatry 152 1995 543 550
57. D.L. Evans, K. Mason, R. Bauer, J. Leserman, J. Petitto Neuropsychiatric manifestations of HIV-1 infection and AIDS D. Charney J. Coyle K. Davis C. Nemeroff Psychopharmacology The Fifth Generation of Progress 2002 Raven Press New York 1281 1300
58. D.L. Evans, C.F. McCartney, J.J. Haggerty Jr, C.B. Nemeroff, R.N. Golden, J.B. Simon Treatment of depression in cancer patients is associated with better life adaptation A pilot study Psychosom Med 50 1988 72 76
59. D.L. Evans, C.F. McCartney, C.B. Nemeroff, D. Raft, D. Quade, R.N. Golden Depression in women treated for gynecological cancer Clinical and neuroendocrine assessment Am J Psychiatry 143 1986 447 452
60. D.L. Evans, T.R. Ten Have, S.D. Douglas Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection Am J Psychiatry 159 2002 1752 1759
61. H. Faller, H. Bulzebruck, P. Drings, H. Lang Coping, distress, and survival among patients with lung cancer Arch Gen Psychiatry 56 1999 756 762
62. F.I. Fawzy, A.L. Canada, N.W. Fawzy Malignant melanoma Effects of a brief, structured psychiatric intervention on survival and recurrence at 10-year follow-up Arch Gen Psychiatry 60 2003 100 103
63. A.K. Ferketich, J.A. Schwartzbaum, D.J. Frid, M.L. Moeschberger Depression as an antecedent to heart disease among women and men in the NHANES I study Arch Intern Med 160 2000 1261 1268
64. F. Fernandez, J.K. Levy, H.R. Samley, F.J. Pirozzolo, D. Lachar, J. Crowley Effects of methylphenidate in HIV-related depression A comparative trial with desipramine Int J Psychiatry Med 25 1995 53 67
65. S.J. Ferrando, J.D. Goldman, W.E. Charness Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS Improvement in affective and somatic symptoms Gen Hosp Psychiatry 19 1997 89 97
66. S.J. Ferrando, J.G. Rabkin, D.M. de Moore, R.R. Rabkin Antidepressant treatment of depression in HIV-seropositive women J Clin Psychiatry 60 1999 741 746
67. D. Fishbain Evidence-based data on pain relief with antidepressants Ann Med 32 2000 305 316
68. D.A. Fishbain, R. Cutler, H.L. Rosomoff, R.S. Rosomoff Chronic pain-associated depression: Antecedent or consequence of chronic pain? A review Clin J Pain 13 1997 116 137
69. L. Fisher, M.M. Skaff, C.A. Chesla, R.A. Kanter, J.T. Mullan Contributors to depression in Latino and European-American patients with type 2 diabetes Diabetes Care 24 2001 1751 1757
70. D.E. Ford, L.A. Mead, P.P. Chang, L. Cooper-Patrick, N.Y. Wang, M.J. Klag Depression is a risk factor for coronary artery disease in men The precursors study Arch Intern Med 158 1998 1422 1426
71. A.W. Forrester, J.R. Lipsey, M.L. Teitelbaum, J.R. DePaulo, P.L. Andrzejewski, R.G. Robinson Depression following myocardial infarction Int J Psychiatry Med 22 1992 33 46
72. L. Forsgren, L. Nystrom An incident case referent study of epileptic seizures in adults Epilepsy Res 6 1990 66 81
73. G.S. Francis, J.N. Cohn, G. Johnson, T.S. Rector, S. Goldman, A. Simon The V-HeFT VA Cooperative Studies Group Plasma norepinephrine, plasma renin activity, and congestive heart failure Relations to survival and the effects of therapy in V-HeFT II Circulation 87 1993 VI40 VI48
74. N. Frasure-Smith, F. Lespérance, M. Juneau, M. Talajic, M.G. Bourassa Gender, depression and one-year prognosis after myocardial infarction Psychosom Med 61 1999 26 37
75. N. Frasure-Smith, F. Lespérance, M. Talajic Depression following myocardial infarction Impact on 6-month survival JAMA 270 1993 1819 1825
76. N. Frasure-Smith, F. Lespérance, M. Talajic Depression and 18-month prognosis after myocardial infarction Circulation 91 1995 999 1005
77. G. Gainotti, G. Antonucci, C. Marra, S. Paolucci Relation between depression after stroke, antidepressant therapy, and functional recovery J Neurol Neurosurg Psychiatry 71 2001 258 261
78. T.L. Gary, R.M. Crum, L. Cooper-Patrick, D. Ford, F.L. Brancati Depressive symptoms and metabolic control in African-Americans with type 2 diabetes Diabetes Care 23 2000 23 29
79. J.A. Gavard, P.J. Lustman, R.E. Clouse Prevalence of depression in adults with diabetes An epidemiological evaluation Diabetes Care 16 1993 1167 1178
80. A.H. Glassman, C.M. O'Connor, R.M. Califf, K. Swedberg, P. Schwartz, J.T. Bigger Jr Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group Sertraline treatment of major depression in patients with acute MI or unstable angina JAMA 288 2002 701 709
81. A.H. Glassman, S.P. Roose, J.T. Bigger Jr The safety of tricyclic antidepressants in cardiac patients Risk/benefit reconsidered JAMA 269 1993 2673 2675
82. K.M. Glazer, C.F. Emery, D.J. Frid, R.E. Banyasz Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation J Cardiopulm Rehab 22 2002 40 46
83. P.W. Gold, K.E. Gabry, M.R. Yasuda, G.P. Chrousos Divergent endocrine abnormalities in melancholic and atypical depression Clinical and pathophysiologic implications Endocrinol Metab Clin North Am 31 2002 37 62
84. J.L. Gonzalez-Torrecillas, J. Mendlewicz, A. Lobo Effects of early treatment of poststroke depression on neuropsychological rehabilitation Int Psychogeriatr 7 1995 547 560
85. K. Goodkin, D.J. Feaster, R. Tuttle, N.T. Blaney, M. Kumar, M.K. Baum Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic human immunodeficiency virus type 1-seropositive homosexual men Clin Diagn Lab Immunol 3 1996 109 118
86. P.J. Goodwin, M. Leszcz, M. Ennis, J. Koopmans, L. Vincent, H. Guther The effect of group psychosocial support on survival in metastatic breast cancer N Engl J Med 345 2001 1719 1726
87. J.M. Gorman, R. Kertzner, T. Cooper, R.R. Goetz, I. Lagomasino, H. Novacenko Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection Am J Psychiatry 148 1991 41 45
88. C. Grade, B. Redford, J. Chrostowski, L. Toussaint, B. Blackwell Methylphenidate in early poststroke recovery A double-blind, placebo-controlled study Arch Phys Med Rehab 79 1998 1047 1050
89. B. Grassi, O. Gambini, Graghentini Efficacy of paroxetine for treatment of depression in the context of HIV infection Pharmacotherapy 30 1997 70 71
90. R.C. Green, L.A. Cupples, A. Kurz, S. Auerbach, R. Go, D. Sandovnick Depression as a risk factor for Alheimer disease The MIRAGE study Arch Neurol 60 2003 752 759
91. M. Grey, R. Whittemore, W. Tamborlane Depression in type 1 diabetes in children Natural history and correlates J Psychosom Res 53 2002 907 911
92. U. Halbreich, S. Palter Accelerated osteoporosis in psychiatric patients Possible pathophysiological processes Schizophr Bull 22 1996 447 454
93. M.H. Halman, J.L. Worth, K.M. Sanders, P.F. Renshaw, G.B. Murray Anticonvulsant use in the treatment of manic syndromes in patients with HIV-1 infection J Neuropsychiatry Clin Neurosci 5 1993 430 434
94. R.A. Hauser, T.A. Zesiewicz Sertraline for the treatment of depression in Parkinson's disease Mov Disord 12 1997 756 759
95. T.B. Herbert, S. Cohen Depression and immunity A meta-analytic review Psychol Bull 113 1993 472 486
96. C. Hermann, S. Brand-Driehorst, U. Buss, U. Ruger Effects of anxiety and depression on 5 year mortality in 5957 patients referred for exercise testing J Psychosom Res 48 2000 455 462
97. D.C. Hesdorffer, W.A. Hauser, J.F. Annegers, G. Cascino Major depression is a risk factor for seizures in older adults Ann Neurol 47 2000 246 249
98. M. Hewitt, J.H. Rowland Mental health service use among adult cancer survivors Analyses of the National Health Interview Survey J Clin Oncol 20 2002 4581 4590
99. M.R. Hibbard, S.E. Grober, W.A. Gordon, E.G. Aletta Modification of cognitive psychotherapy for the treatment of post-stroke depression Behav Ther 13 1990 15 17
100. C.C. Hoch, C.F. Reynolds, D.J. Buysse, A.L. Fasiczka Two-year survival patients with mixed symptoms of depression and cognitive impairment Comparison with major depression and primary degenerative dementia Am J Geriatr Psychiatry 1 1993 59 66
101. J.C. Holland, S.J. Romano, J.H. Heiligenstein, R.G. Tepner, M.G. Wilson A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer Psychooncology 7 1998 291 300
102. A. House, M. Dennis, C. Warlow, K. Hawton, A. Molyneaux The relationship between intellectual impairment and mood disorder in the first year after stroke Psychol Med 20 1990 805 814
103. A. House, P. Knapp, J. Bamford, A. Vail Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month Stroke 32 2001 696 701
104. J.R. Ickovics, M.E. Hamburger, D. Vlahov, E.E. Schoenbaum, P. Schuman, R.J. Boland, J. Moore HIV Epidemiology Research Study Group Mortality, CD4 cell count decline, and depressive symptoms among HIV-seropositive women Longitudinal analysis from the HIV Epidemiology Research Study JAMA 285 2001 1466 1474
105. A. Ilnyckyj, J. Farber, M.C. Cheang, B.H. Weinerman A randomized controlled trial of psychotherapeutic intervention in cancer patients Ann R Coll Physicians Surg Can 27 1994 93 96
106. T.R. Insel, D.S. Charney Research on major depression JAMA 289 2003 3167 3168
107. G. Ironson, E. Balbin, G. Solomon, N. Schneiderman, J. Fahey, M.A. Fletcher Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 counts AIDS 15 2001 2065 2073
108. J.I. Isojarvi, J. Rattya, V.V. Myllyla, M. Knip, R. Koivunen, A.J. Pakarinen Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy Ann Neurol 43 1998 446 451
109. W. Jiang, M. Babyak, D.S. Krantz, R.A. Waugh, E. Coleman, M.M. Hanson Mental stress-induced myocardial ischemia and cardiac events JAMA 275 1996 1651 1656
110. R.E. Jorge, R.G. Robinson, S. Arndt, S.E. Starkstein Mortality and post-stroke depression A placebo controlled trial of antidepressants Am J Psychiatry 160 2003 1823 1829
111. A.M. Kanner Depression in epilepsy Prevalence, clinical semiology, pathogenic mechanisms, and treatment Biol Psychiatry 54 2003 388 398
112. M. Kauhanen, J.T. Korpelainen, P. Hiltunen, E. Brusin, H. Mononen, R. Määttä Poststroke depression correlates with cognitive impairment and neurological deficits Stroke 30 1999 1875 1880
113. N. Kawakami, N. Takatsuka, H. Shimizu, H. Ishibashi Depressive symptoms and occurrence of type 2 diabetes among Japanese men Diabetes Care 22 1999 1071 1076
114. F.J. Keefe Can cognitive-behavioral therapies succeed where medical treatments fail? M. Devor M.C. Rowbotham Z. Wiesenfeld-Hallin Proceedings of the 9th World Congress on Pain Progress in Pain Research and Management 16 2000 IASP Press Seattle, Washington 1069 1084
115. M.E. Kemeny, L. Dean Effects of AIDS-related bereavement on HIV progression among New York City gay men AIDS Educ Prev 7 suppl 1995 36 47
116. M.E. Kemeny, H. Weiner, R. Duran, S.E. Taylor, B. Visscher, J.L. Fahey Immune system changes after the death of a partner in HIV-positive gay men Psychosom Med 57 1995 547 554
117. R.C. Kessler, K.A. McGonagle, S. Zhao, C.B. Nelson, M. Hughes, S. Eshleman Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey Arch Gen Psychiatry 51 1994 8 19
118. R.C. Kessler, E.E. Walters Epidemiology of DSM-III-R major depression and minor depression among adolescents and young adults in the National Comorbidity Survey Depress Anxiety 7 1998 3 14
119. K. Kieburtz, A.E. Zettelmaier, L. Ketonen, M. Tuite, E.D. Caine Manic syndrome in AIDS Am J Psychiatry 148 1991 1068 1070
120. M. Kimura, R.G. Robinson, J.T. Kosier Treatment of cognitive impairment after poststroke depression a double-blind treatment trial Stroke 31 2000 1482 1486
121. H.G. Koenig, H.J. Cohen, D.G. Blazer, C. Pieper, K.G. Meador, F. Shelp Religious coping and depression among elderly, hospitalized medically ill men Am J Psychiatry 149 1992 1693 1700
122. W.J. Kop, J.S. Gottdiener, C.M. Tangen, L.P. Fried, M.A. McBurnie, J. Walston Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia Am J Cardiol 89 2002 419 424
123. C.E. Koro, D.O. Fedder, G.J. L'Italien, S.S. Weiss, L.S. Magder, J. Kreyenbuhl Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia Population based nested case-control study BMJ 325 2002 243 245
124. K.R. Krishnan, J.C. Hays, D.G. Blazer MRI-defined vascular depression Am J Psychiatry 154 1997 497 501
125. T. Kuchler, D. Henne-Burns, S. Rappat, J. Graul, K. Holst, J.I. Williams, S. Wood-Dauphinee Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery Survival results of a trial Hepatogastroenterology 46 1999 322 335
126. W. Kuhn, N. Heye, T. Muller, P. Kraus, P. Klotz, B. Friedrich The motor performance test series in Parkinson's disease is influenced by depression J Neural Trans 103 1996 349 354
127. P.M.J.C. Kuijpers, K. Hamulyak, J.J.M.H. Strik, H.J.J. Wellens, A. Honig Beta-thromboglobulin and platelet factor 4 levels in post-myocardial infarction patients with major depression Psychiatry Res 109 2002 207 210
128. A.M. Kuopio, R.J. Marttila, H. Helenius, M. Toivonen, U.K. Rinne The quality of life in Parkinson's disease Mov Disord 15 2000 216 223
129. G. Kuzis, L. Sabe, C. Tiberti, R. Leiguarda, S.E. Starkstein Cognitive functions in major depression and Parkinson's disease Arch Neurol 54 1997 982 986
130. F. Laghrissi-Thode, W.R. Wagner, B.G. Pollock, P.C. Johnson, M.S. Finkel Elevated platelet factor 4 and β-thromboglobulin plasma levels in depressed patients with ischemic heart disease Biol Psychiatry 42 1997 290 295
131. L. Laitinen Desipramine in treatment of Parkinson's disease Acta Neurol Scand 45 1969 109 113
132. S.L. Larson, P.L. Owens, D. Ford, W. Eaton Depressive disorder, dysthymia, and risk of stroke Thirteen-year follow-up from the Baltimore Epidemiologic Catchment Area Study Stroke 32 2001 1978 1983
133. F. Lederbogen, M. Gilles, A. Maras, B. Hamann, M. Colla, I. Heuser, M. Deuschle Increased platelet aggregability in major depression? Psychiatry Res 102 2001 255 261
134. H.B. Lee, C.G. Lyketsos Depression in Alzheimer's disease Heterogeneity and related issues Biol Psychiatry 54 2003 353 362
135. G. Lera, J. Zirulnik Pilot study with clozapine in patients with HIV-associated psychosis and drug-induced parkinsonism Mov Disord 14 1999 128 131
136. J. Leserman HIV disease progression Depression, stress, and possible mechanisms Biol Psychiatry 54 2003 295 306
137. J. Leserman, E.D. Jackson, J.M. Petitto, R.N. Golden, S.G. Silva, D.O. Perkins Progression to AIDS The effects of stress, depressive symptoms, and social support Psychosom Med 61 1999 397 406
138. J. Leserman, J.M. Petitto, H. Gu, B.N. Gaynes, J. Barroso, R.N. Golden Progression to AIDS, a clinical AIDS condition and mortality Psychosocial and physiological predictors Psychol Med 32 2002 1059 1073
139. J. Leserman, J.M. Petitto, D.O. Perkins, J.D. Folds, R.N. Golden, D.L. Evans Severe stress, depressive symptoms, and changes in lymphocyte subsets in human immunodeficiency virus-infected men A 2-year follow-up study Arch Gen Psychiatry 54 1997 279 285
140. F. Lespérance, N. Frasure-Smith, M. Talajic, M.G. Bourassa Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction Circulation 105 2002 1049 1053
141. K. Lillberg, P.K. Verkasalo, J. Kaprio, L. Teppo, H. Helenius, M. Koskenvuo Stressful life events and risk of breast cancer in 10,808 women A cohort study Am J Epidemiol 157 2003 415 423
142. M.W. Linn, B.S. Linn, R. Harris Effects of counseling for late stage cancer patients Cancer 49 1982 1048 1055
143. J.R. Lipsey, R.G. Robinson, G.D. Pearlson, K. Rao, T.R. Price Nortriptyline treatment of post-stroke depression A double-blind study Lancet 1 1984 297 300
144. J.D. Lipsitz, J.B.W. Williams, J.G. Rabkin, R.H. Remien, M. Bradbury, W. el Sadr Psychopathology in male and female intravenous drug users with and without HIV infection Am J Psychiatry 151 1994 1662 1668
145. P.J. Lustman, R.J. Anderson, K.E. Freedland, M. de Groot, R.M. Carney, R.E. Clouse Depression and poor glycemic control A meta-analytic review of the literature Diabetes Care 23 2000 934 942
146. P.J. Lustman, K.E. Freedland, L.S. Griffith, R.E. Clouse Fluoxetine for depression in diabetes A randomized, double-blind, placebo-controlled trial Diabetes Care 23 2000 618 623
147. P.J. Lustman, L.S. Griffith, R.E. Clouse, K.E. Freedland, S.A. Eisen, E.H. Rubin Effects of nortriptyline on depression and glycemic control in diabetes Results of a double-blind, placebo-controlled trial Psychosom Med 59 1997 241 250
148. P.J. Lustman, L.S. Griffith, K.E. Freedland, S.S. Kissel, R.E. Clouse Cognitive behavior therapy for depression in type 2 diabetes mellitus A randomized, controlled trial Ann Intern Med 129 1998 613 621
149. C.G. Lyketsos, L. DelCampo, M. Steinberg, Q. Miles, C.D. Steele, C. Munro Treating depression in Alzheimer disease: Efficacy and safety of sertraline therapy, and the benefits of depression reduction. The DIADS Arch Gen Psychiatry 60 2003 737 746
150. C.G. Lyketsos, D.R. Hoover, M. Guccione, M.A. Dew, J.E. Wesch, E.G. Bing, G.J. Treisman Multicenter AIDS Cohort Study Changes in depressive symptoms as AIDS develops Am J Psychiatry 153 1996 1430 1437
151. C.G. Lyketsos, D.R. Hoover, M. Guccione, W. Senterfitt, M.A. Dew, J. Wesch Depressive symptoms as predictors of medical outcomes in HIV infection JAMA 270 1993 2563 2567
152. C.G. Lyketsos, J. Schwartz, M. Fishman, G. Treisman AIDS mania J Neuropsychiatry Clin Neurosci 9 1997 277 279
153. C.G. Lyketsos, C. Steele, L. Baker, E. Galik, S. Kopunek, M. Steinberg Major and minor depression in Alzheimer's disease Prevalence and impact J Neuropsychiatry Clin Neurosci 9 1997 556 561
154. M.E. Lynch Antidepressants as analgesics A review of randomized controlled trials J Psychiatry Neurosci 26 2001 30 36
155. J.W. Maas, M.M. Katz, S.H. Koslow, A. Swann, J.M. Davis, N. Berman Adrenomedullary function in depressed patients J Psychiatr Res 28 1994 357 367
156. C. Magai, G. Kennedy, C.I. Cohen, D. Gomberg A controlled clinical trial of sertraline in the treatment of depression nursing home patients with late-stage Alzheimer's disease Am J Geriatr Psychiatry 8 2000 66 74
157. E. Maggi, M. Mazzetti, A. Ravina, F. Annunziato, M. De Carli, M.P. Piccinni Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells Science 265 1994 244 248
158. J.D. Maggi, M.H. Halman The effect of divalproex sodium on viral load A retrospective review of HIV-positive patients with manic syndromes Can J Psychiatry 46 2001 359 362
159. M. Maj Depressive syndromes and symptoms in subjects with human immunodeficiency virus (HIV) infection Br J Psychiatry 168 suppl 30 1996 117 122
160. M. May, P. McCarron, S. Stansfeld, Y. Ben-Shlomo, J. Gallacher, J. Yarnell Does psychological distress predict the risk of ischemic stroke and transient ischemic attack? The Caerphilly Study Stroke 33 2002 7 12
161. R. Mayeux, Y. Stern, J. Rosen, J. Leventhal Depression, intellectual impairment, and Parkinson's disease Neurology 31 1981 645 650
162. T.J. Mayne, E. Vittinghoff, M.A. Chesney, D.C. Barrett, T.J. Coates Depressive affect and survival among gay and bisexual men infected with HIV Arch Intern Med 156 1996 2233 2238
163. R. McCorkle, N.E. Strumpf, I.F. Nuamah, D.C. Adler, M.E. Cooley, C. Jepson A specialized home care intervention improves survival among older post-surgical cancer patients J Am Geriatr Soc 48 2000 1707 1713
164. J.S. McDaniel, D.L. Musselman, M.R. Porter, D.A. Reed, C.B. Nemeroff Depression in patients with cancer Diagnosis, biology, and treatment Arch Gen Psychiatry 52 1995 89 99
165. W.M. McDonald, I.H. Richard, M.R. DeLong The prevalence, etiology and treatment of depression in Parkinson's disease Biol Psychiatry 54 2003 363 375
166. J.L. Montastruc, N. Fabre, O. Blin, J.M. Senard, O. Rascol, A. Rascol Does fluoxetine aggravate Parkinson's disease? A pilot prospective study Mov Disord 10 1995 355 357
167. P.L.P. Morris, R.G. Robinson, P. Andrezejewski, J. Samuels, T.R. Price Association of depression with 10-year post-stroke mortality Am J Psychiatry 150 1993 124 129
168. M.F. Morrison, J.M. Petitto, T. Ten Have, D.R. Gettes, M.S. Chiappini, A.L. Weber Depressive and anxiety disorders in women with HIV infection Am J Psychiatry 159 2002 789 796
169. R. Mössner, A. Henneberg, A. Schmitt, Y.V. Syagailo, M. Grässle, T. Hennig Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease Mol Psychiatry 6 2001 350 352
170. K.L. Movig, M.W. Janssen, J. de Waal Malefijt, P.J. Kabel, H.G. Leufkens, A.C. Egberts Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients Arch Intern Med 163 2003 2354 2358
171. G.B. Murray, V. Shea, D.K. Conn Electroconvulsive therapy for poststroke depression J Clin Psychiatry 47 1986 258 260
172. D.L. Musselman, E. Betan, H. Larsen, L.S. Phillips The relationship of depression to diabetes-Type 1 and Type 2 Epidemiology, biology, and treatment Biol Psychiatry 54 2003 317 329
173. D.L. Musselman, D.L. Evans, C.B. Nemeroff The relationship of depression to cardiovascular disease Arch Gen Psychiatry 55 1998 580 592
174. D.L. Musselman, D.H. Lawson, J.F. Gumnick, A.K. Manatunga, S. Penna, R.S. Goodkin Paroxetine for the prevention of the depression induced by high dose interferon-alpha N Engl J Med 344 2001 961 966
175. D.L. Musselman, U. Marzec, M. Davidoff, A.K. Manatunga, F. Gao, A. Reemsnyder Platelet activation and secretion in patients with major depression, thoracic aortic atherosclerosis, or renal dialysis treatment Depress Anxiety 15 2002 91 101
176. D.L. Musselman, U.M. Marzec, A. Manatunga, S. Penna, A. Reemsnyder, B.T. Knight Platelet reactivity in depressed patients treated with paroxetine Preliminary findings Arch Gen Psychiatry 57 2000 875 882
177. D.L. Musselman, A.H. Miller, M.R. Porter, A. Manatunga, F. Gao, S. Penna Higher than normal plasma interleukin-6 concentrations in cancer patients with depression Preliminary findings Am J Psychiatry 158 2001 1252 1257
178. D.L. Musselman, A. Tomer, A.K. Manatunga, B.T. Knight, M.R. Porter, S. Kasey Exaggerated platelet reactivity in major depression Am J Psychiatry 153 1996 1313 1317
179. M.P. Nair, S.A. Schwartz Synergistic effect of cortisol and HIV-1 envelope peptide on the NK activities of normal lymphocytes Brain Behav Immun 9 1995 20 30
180. M.P.N. Nair, S. Mahajan, J. Hou, A.M. Sweet, S.A. Schwartz The stress hormone, cortisol, synergizes with HIV-1 gp-120 to induce apoptosis of normal human peripheral blood mononuclear cells Cell Mol Biol 46 2000 1227 1238
181. K. Narushima, J.T. Kosier, R.G. Robinson Preventing of post-stroke depression A 12 week double-blind randomized treatment trial with 21 month follow-up J Nerv Ment Dis 190 2002 296 303
182. K. Narushima, J.T. Kosier, R.G. Robinson A reappraisal of post-stroke depression, intra and inter-hemispheric lesion location using meta-analysis J Neuropsychiatry Clin Neurosci 15 2003 422 430
183. D.J. Newport, C.B. Nemeroff Assessment and treatment of depression in the cancer patient J Psychosom Res 45 1998 215 237
184. A.L. Nyth, C.G. Gottfries The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders A Nordic multicentre study Br J Psychiatry 157 1990 894 901
185. A.L. Nyth, C.G. Gottfries, K. Lyby, L. Smedegaard-Anderson, J. Gylding-Sabroe, M. Kristensen A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia Acta Psychiatr Scand 85 1992 138 145
186. J.T. Olin, L.S. Schneider, I.R. Katz, B.S. Meyers, G.S. Alexopoulos, J.C. Breitner Provisional diagnostic criteria for depression of Alzheimer's disease Am J Geriatr Psychiatry 10 2002 125 128
187. K. Page-Shafer, G.N. Delorenze, W.A. Satariano, W. Winkelstein Jr Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey Ann Epidemiol 6 1996 420 430
188. H. Palomäki, M. Kaste, A. Berg, R. Lönnqvist, J. Lönnqvist, M. Lehtihalmes, J. Hares Prevention of poststroke depression 1 year randomized placebo controlled double blind trial of mianserin with 6 month follow up after therapy J Neurol Neurosurg Psychiatry 66 1999 490 494
189. D.M. Parenti, G.L. Simon, R.G. Scheib, W.A. Meyer III, M.B. Sztein, H. Paxton Effect of lithium carbonate in HIV-infected patients with immune dysfunction J Acquir Immune Defic Syndr 1 1988 119 124
190. T.L. Patterson, W.S. Shaw, S.J. Semple, M. Cherner, A. McCutchan, J.H. Atkinson Relationship of psychosocial factors to HIV disease progression Ann Behav Med 18 1996 30 39
191. B.W. Penninx, J.M. Guralnik, M. Pahor, L. Ferrucci, J.R. Cerhan, R.B. Wallace, R.J. Havlik Chronically depressed mood and cancer risk in older persons J Natl Cancer Inst 90 1998 1888 1893
192. S.R. Penzak, Y.S. Reddy, S.R. Grimsley Depression in patients with HIV infection Am J Health Syst Pharm 7 2000 376 389
193. G.S. Pepper, R.W. Lee Sympathetic activation in heart failure and its treatment with beta-blockade Arch Intern Med 159 1999 225 234
194. D.O. Perkins, J. Leserman, R.A. Stern, S.F. Baum, D. Liao, R.N. Golden, D.L. Evans Somatic symptoms and HIV infection Relationship to depressive symptoms and indicators of HIV disease Am J Psychiatry 152 1995 1776 1781
195. D.O. Perkins, R.A. Stern, R.N. Golden, C. Murphy, D. Naftolowitz, D.L. Evans Mood disorders in HIV infection Prevalence and risk factors in a nonepicenter of the AIDS epidemic Am J Psychiatry 151 1994 233 236
196. P. Perretta, H.S. Akiskal, C. Nisita, C. Lorenzetti, E. Zaccagnini, M. Della Santa, G.B. Cassano The high prevalence of bipolar II and associated cyclothymic and hyperthymic temperaments in HIV-patients J Affect Disord 50 1998 215 224
197. J.M. Petitto, J. Leserman, D.O. Perkins, R.A. Stern, S.G. Silva, D. Gettes High versus low basal cortisol secretion in asymptomatic, medication-free HIV-infected men Differential effects of severe life stress on parameters of immune status Behav Med 25 2000 143 151
198. G.M. Petracca, E. Chemerinski, S.E. Starkstein A double-blind placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease Int Psychogeriatr 13 2001 233 240
199. G.M. Petracca, A. Teson, E. Chemerinski, R. Leiguarda, S.E. Starkstein A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease J Neuropsychiatry Clin Neurosci 8 1996 270 275
200. M. Petticrew, R. Bell, D. Hunter Influence of psychological coping on survival and recurrence in people with cancer Systematic review BMJ 325 2002 1066 1069
201. M. Peyrot, R.R. Rubin Levels and risks of depression and anxiety symptomatology among diabetic adults Diabetes Care 20 1997 585 590
202. G. Pezzella, R. Moslinger-Gehmayr, A. Contu Treatment of depression in patients with breast cancer A comparison between paroxetine and amitriptyline Breast Cancer Res Treat 70 2001 1 10
203. P. Phillips Keeping depression at bay helps patients with Parkinson's disease JAMA 282 1999 1118 1119
204. D.S. Pine, R.B. Goldstein, S. Wolk, M.M. Weissman The association between childhood depression and adulthood body mass index Pediatrics 107 2001 1049 1056
205. S.C. Piscitelli, A.H. Burstein, D. Chaitt, R.M. Alfaro, J. Falloon Indinavir concentrations and St John's wort Lancet 355 2000 547 548
206. P.M. Plotsky, M.J. Owens, C.B. Nemeroff Psychoneuroendocrinology of depression Hypothalamic-pituitary-adrenal axis Psychiatr Clin North Am 1 1998 293 307
207. B.G. Pollock, F. Laghrissi-Thode, W.R. Wagner Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment J Clin Psychopharmacol 20 2000 137 140
208. J.G. Rabkin, S.J. Ferrando, G.J. Wagner, R. Rabkin DHEA treatment for HIV+ patients Effects on mood, androgenic and anabolic parameters Psychoneuroendocrinology 25 2000 53 68
209. J.G. Rabkin, J. Johnson, S.H. Lin, J.D. Lipsitz, R.H. Remien, J.B.W. Williams, J.M. Gorman Psychopathology in male and female HIV-positive and negative injecting drug users Longitudinal course over 3 years AIDS 11 1997 507 515
210. J.G. Rabkin, R. Rabkin, W. Harrison, G. Wagner Effect of imipramine on mood and enumerative measures of immune status in depressed patients with HIV illness Am J Psychiatry 151 1994 516 523
211. J.G. Rabkin, R. Rabkin, G. Wagner Effects of fluoxetine on mood and immune status in depressed patients with HIV illness J Clin Psychiatry 55 1994 92 97
212. J.G. Rabkin, G. Wagner, R. Rabkin Effects of sertraline on mood and immune status in patients with major depression and HIV illness An open trial J Clin Psychiatry 55 1994 433 439
213. J.G. Rabkin, G. Wagner, R. Rabkin Fluoxetine treatment for depression in patients with HIV and AIDS A randomized, placebo-controlled trial Am J Psychiatry 156 1999 101 107
214. J.G. Rabkin, G.J. Wagner, R. Rabkin A double-blind, placebo-controlled trial of testosterone therapy for HIV-positive men with hypogonadal symptoms Arch Gen Psychiatry 57 2000 141 147
215. C.L. Raison, A.H. Miller Depression in cancer New developments regarding diagnosis and treatment Biol Psychiatry 54 2003 283 294
216. C.L. Raison, C.B. Nemeroff Cancer and depression Prevalence, diagnosis, and treatment Home Health Care Consultant 7 2000 34 41
217. L. Rampello, S. Chiechio, R. Raffaele, I. Vecchio, F. Nicoletti The SSRI, citalopram, improves bradykinesia in patients with Parkinson's disease treated with L-dopa Clin Neuropharmacol 25 2002 21 24
218. A. Rasmussen, M. Lunde, D.L. Poulsen, K. Sorensen, S. Qvitzau, P. Bech A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients Psychosomatics 4 2003 216 221
219. D. Razavi, J.F. Allilaire, M. Smith, A. Salimpour, M. Verra, B. Desclaux The effect of fluoxetine on anxiety and depression symptoms in cancer patients Acta Psychiatr Scand 94 1996 205 210
220. M.J. Reding, L.A. Orto, S.W. Winter, I.M. Fortuna, P. DiPonte, F.H. McDowell Antidepressant therapy after stroke a double-blind trial Arch Neurol 43 1986 763 765
221. W.T. Regenold, R.K. Thapar, C. Marano, S. Gavireni, P.V. Kondapavuluru Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use J Affect Disord 70 2002 19 26
222. D.A. Regier, M.E. Farmer Comorbidity of mental disorders with alcohol and other drug abuse JAMA 264 1990 2511 2518
223. B.V. Reifler, L. Teri, M. Raskind, R. Veith, R. Barnes, E. White, P. McLean Double-blind trial of imipramine in Alzheimer's disease patients with and without depression Am J Psychiatry 146 1989 45 49
224. I.H. Richard, A. Maughn, R. Kurlan Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series Mov Disord 14 1999 155 157
225. J.L. Richardson, D.R. Shelton, M. Krailo, A.M. Levine The effect of compliance with treatment on survival among patients with hematologic malignancies J Clin Oncol 8 1990 356 364
226. M.M. Robertson Suicide, parasuicide, and epilepsy J. Engel T.A. Pedley Epilepsy A Comprehensive Textbook 1997 Lippincott-Raven Philadelphia
227. M.M. Robertson, M.R. Trimble The treatment of depression in patients with epilepsy J Affect Disord 9 1985 127 136
228. R.G. Robinson Post-stroke depression Prevalence, diagnosis, treatment and disease progression Biol Psychiatry 54 2003 376 387
229. R.G. Robinson, J.R. Lipsey, K. Rao, T.R. Price Two-year longitudinal study of post-stroke mood disorders Comparison of acute-onset with delayed-onset depression Am J Psychiatry 143 1986 1238 1244
230. R.G. Robinson, S.K. Schultz, C. Castillo, T. Kopel, J.T. Kosier, M. Newman Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke a placebo-controlled, double-blind study Am J Psychiatry 157 2000 351 359
231. R.G. Robinson, L.B. Starr, J.R. Lipsey, K. Rao, T.R. Price A two-year longitudinal study of post-stroke mood disorders In-hospital prognostic factors associated with six month outcome J Nerv Ment Dis 173 1985 221 226
232. S.P. Roose, G.W. Dalack, A.H. Glassman, S. Woodring, B.T. Walsh, E.G.V. Giardina Cardiovascular effects of bupropion in depressed patients with heart disease Am J Psychiatry 148 1991 512 516
233. S.P. Roose, A.H. Glassman, E. Attia, S. Woodring, E.G.V. Giardina, J.T. Bigger Jr Cardiovascular effects of fluoxetine in depressed patients with heart disease Am J Psychiatry 155 1998 660 665
234. S.P. Roose, F. Laghrissi-Thode, J.S. Kennedy, C. Nelson, J.T. Bigger Jr, B.G. Pollock Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease JAMA 279 1998 287 291
235. R. Rosmond, P. Bjorntorp The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke J Intern Med 247 2000 188 197
236. M. Roth, C.Q. Mountjoy, R. Amrein Moclobemide in elderly patients with cognitive decline and depression An international double-blind, placebo-controlled trial Br J Psychiatry 168 1996 149 157
237. A. Rozanski, J.A. Blumenthal, J. Kaplan Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy Circulation 99 1999 2192 2217
238. B. Rudisch, C.B. Nemeroff Epidemiology of comorbid coronary artery disease and depression Biol Psychiatry 54 2003 227 240
239. W.H. Sauer, J.A. Berlin, S.E. Kimmel Selective serotonin reuptake inhibitors and myocardial infarction Circulation 104 2001 1894 1898
240. V.L. Serebruany, A.H. Glassman, A.I. Malinin, C.B. Nemeroff, D. Musselman, L.T. van Zyl SADHART Study Group Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events The Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy Circulation 108 2003 939 944
241. V.L. Serebruany, P.A. Gurbel, C.M. O'Connor Platelet inhibition by sertraline and N-desmethylsertraline A possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors Pharmacol Res 43 2001 453 461
242. V.L. Serebruany, C.M. O'Connor, P.A. Gurbel Effect of selective serotonin reuptake inhibitors on platelets in patients with coronary artery disease Am J Cardiol 87 2001 1398 1400
243. D.S. Sheps, R.P. McMahon, L. Becker, R.M. Carney, K.E. Freedland, J.D. Cohen Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease Results from the Psychophysiological Investigations of Myocardial Ischemia study Circulation 105 2002 1780 1784
244. A.N. Singh, H. Golledge, J. Catalan Treatment of HIV-related psychotic disorders with risperidone A series of 21 cases J Psychosom Res 42 1997 489 493
245. D. Spiegel, J.R. Bloom, H.C. Kraemer, E. Gottheil Effect of psychosocial treatment on survival of patients with metastatic breast cancer Lancet 2 1989 888 891
246. D. Spiegel, J. Giese-Davis Depression and cancer mechanisms and disease progression Biol Psychiatry 54 2003 269 282
247. C. Steele, B. Rovner, G.A. Chase, M. Folstein Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease Am J Psychiatry 147 1990 1049 1051
248. D.C. Steffens, K.R.R.K. Krishnan, C. Crump, G.L. Burke Cerebrovascular disease and evolution of depressive symptoms in the Cardiovascular Health Study Stroke 33 2002 1636 1644
249. R.A. Stern, N.G. Singer, S.G. Silva, H.J. Rogers, D.O. Perkins, C.D. Hall Neurobehavioral functioning in a nonconfounded group of asymptomatic HIV-seropositive homosexual men Am J Psychiatry 149 1992 1099 1102
250. M. Stommel, B.A. Given, C.W. Given Depression and functional status as predictors of death among cancer patients Cancer 94 2002 2719 2727
251. R. Strang Imipramine in treatment of parkinsonism A double blind placebo study Br Med J 2 1965 33 34
252. A.J. Stunkard, M.S. Faith, K.C. Allison Depression and obesity Biol Psychiatry 54 2003 330 337
253. D.E. Theobald, K.L. Kirsh, E. Holtsclaw, K. Donaghy, S.D. Passik An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms J Pain Symptom Manage 23 2002 442 447
254. A.J. Thomas, I.N. Ferrier, R.N. Kalaria, S.A. Woodward, C. Ballard, A. Oakley Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex Am J Psychiatry 157 2000 1682 1684
255. G. Treisman, M. Fishman, J. Schwartz, H. Hutton, C. Lyketsos Mood disorders in HIV infection Depress Anxiety 7 1998 178 187
256. A.I. Troster, L.D. Stalp, A.M. Paolo, J.A. Fields, W.C. Koller Neuropsychological impairment in Parkinson's disease with and without depression Arch Neurol 52 1995 1164 1169
257. M.T. Tsuang, R.F. Woolson, J.A. Fleming Causes of death in schizophrenia and manic-depression Br J Psychiatry 136 1980 239 242
258. T. Vago, M. Clerici, G. Norbiato Glucocorticoids and the immune system in AIDS Baillieres Clin Endocrinol Metab 8 1994 789 802
259. K. van Heeringen, M. Zivkov Pharmacological treatment of depression in cancer patients A placebo-controlled study of mianserin Br J Psychiatry 169 1996 440 443
260. C. van Walraven, M.M. Mamdani, P.S. Wells, J.I. Williams Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients Retrospective cohort study BMJ 323 2001 655 658
261. R. von Känel, P.J. Mills, C. Fainman, J.E. Dimsdale Effects of psychological stress and psychiatric disorders on blood coagulation and fibrinolysis A biobehavioral pathway to coronary artery disease? Psychosom Med 63 2001 531 544
262. D.T. Wade, J. Legh-Smith, R.A. Hewer Depressed mood after stroke, a community study of its frequency Br J Psychiatry 151 1987 200 205
263. G.J. Wagner, R. Rabkin Effects of dextroamphetamine on depression and fatigue in men with HIV A double-blind, placebo-controlled trial J Clin Psychiatry 61 2000 436 440
264. G.J. Wagner, J.G. Rabkin, R. Rabkin Dextroamphetamine as a treatment for depression and low energy in AIDS patients A pilot study J Psychosom Res 42 1997 407 411
265. P.S. Wang, R.L. Bohn, E. Knight, R.J. Glynn, H. Mogun, J. Avorn Noncompliance with antihypertensive medications The impact of depressive symptoms and psychosocial factors J Gen Intern Med 17 2002 504 511
266. J.K. Warnock, E.M. Mutzig Diabetes mellitus and major depression Considerations for treatment of Native Americans J Okla State Med Assoc 91 1998 488 493
267. L.L. Watkins, P. Grossman Association of depressive symptoms with reduced baroreflex cardiac control in coronary artery disease Am Heart J 137 1999 453 457
268. A. Weeke, K. Juel, M. Vaeth Cardiovascular death and manic-depressive psychosis J Affect Disord 13 1987 287 292
269. L. Wiart, H. Petit, P.A. Joseph, J.M. Mazaux, M. Barat Fluoxetine in early poststroke depression A double-blind placebo-controlled study Stroke 31 2000 1829 1832
270. Writing Committee for the ENRICHD Investigators Effects of treating depression and low perceived social support on clinical events after myocardial infarction. The Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial JAMA 289 2003 3106 3116
271. V.K. Yeragani Major depression and long-term heart period variability Depress Anxiety 12 2000 51 52
272. V.K. Yeragani, R. Pohl, V.C. Jampala, R. Balon, C. Ramesh, K. Srinivasan Increased QT variability in patients with panic disorder and depression Psychiatry Res 93 2000 225 235
273. S. Zisook, J. Perterkin, K.J. Goggin, P. Sledge, J.H. Atkinson, I. Grant HIV Neurobehavioral Research Center Group Treatment of major depression in HIV-seropositive men J Clin Psychiatry 59 1998 217 224
274. G.S. Zubenko, W.N. Zubenko, S. McPherson, E. Spoor, D.B. Marin, M.R. Farlow A collaborative study of the emergence and clinical features of major depressive syndrome of Alzheimer's disease Am J Psychiatry 160 2003 857 866